These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study. Muanda FT; Weir MA; Ahmadi F; Sontrop JM; Cowan A; Fleet JL; Blake PG; Garg AX Am J Kidney Dis; 2022 Jul; 80(1):98-107.e1. PubMed ID: 34979160 [TBL] [Abstract][Full Text] [Related]
3. Association of Baclofen With Encephalopathy in Patients With Chronic Kidney Disease. Muanda FT; Weir MA; Bathini L; Blake PG; Chauvin K; Dixon SN; McArthur E; Sontrop JM; Moist L; Garg AX JAMA; 2019 Nov; 322(20):1987-1995. PubMed ID: 31705755 [TBL] [Abstract][Full Text] [Related]
4. Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. Muanda FT; Sood MM; Weir MA; Sontrop JM; Ahmadi F; Yoo E; Kim RB; Silverman MS; Knoll GA; Garg AX JAMA Netw Open; 2022 Aug; 5(8):e2224892. PubMed ID: 35917124 [TBL] [Abstract][Full Text] [Related]
5. Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study. Bathini L; Garg AX; Sontrop JM; Weir MA; Blake PG; Dixon SN; McArthur E; Muanda FT Am J Kidney Dis; 2022 Dec; 80(6):730-739. PubMed ID: 35644439 [TBL] [Abstract][Full Text] [Related]
6. High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol. Abdullah SS; Rostamzadeh N; Muanda FT; McArthur E; Weir MA; Sontrop JM; Kim RB; Kamran S; Garg AX Can J Kidney Health Dis; 2024; 11():20543581231221891. PubMed ID: 38186562 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function. Edwards C; Hundemer GL; Petrcich W; Canney M; Knoll G; Burns K; Bugeja A; Sood MM JAMA Netw Open; 2021 Sep; 4(9):e2123365. PubMed ID: 34524440 [TBL] [Abstract][Full Text] [Related]
8. Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease. Olar P; Garg AX; Weir MA; Ahmadi F; McArthur E; Lam NN; Sontrop JM; Muanda FT Pharmacol Res Perspect; 2024 Dec; 12(6):e70028. PubMed ID: 39428714 [TBL] [Abstract][Full Text] [Related]
9. Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD. Muanda FT; Weir MA; Bathini L; Clemens KK; Perkovic V; Sood MM; McArthur E; Sontrop JM; Kim RB; Garg AX Clin J Am Soc Nephrol; 2020 Dec; 15(12):1728-1739. PubMed ID: 33239410 [TBL] [Abstract][Full Text] [Related]
10. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study. Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153 [TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics. Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574 [TBL] [Abstract][Full Text] [Related]
12. Interventions for cutaneous disease in systemic lupus erythematosus. Hannon CW; McCourt C; Lima HC; Chen S; Bennett C Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction. Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S Rheumatol Int; 2020 May; 40(5):765-770. PubMed ID: 32170389 [TBL] [Abstract][Full Text] [Related]
14. Accounting for Age in the Definition of Chronic Kidney Disease. Liu P; Quinn RR; Lam NN; Elliott MJ; Xu Y; James MT; Manns B; Ravani P JAMA Intern Med; 2021 Oct; 181(10):1359-1366. PubMed ID: 34459844 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ; PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420 [TBL] [Abstract][Full Text] [Related]
17. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299 [TBL] [Abstract][Full Text] [Related]
18. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis. Farag A; Garg AX; Li L; Jain AK Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475 [TBL] [Abstract][Full Text] [Related]
19. Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada. Ravani P; Quinn R; Fiocco M; Liu P; Al-Wahsh H; Lam N; Hemmelgarn BR; Manns BJ; James MT; Joanette Y; Tonelli M JAMA Netw Open; 2020 Sep; 3(9):e2017150. PubMed ID: 32945876 [TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. He M; Pawar A; Desai RJ; Glynn RJ; Lee H; Weinblatt ME; Solomon DH; Kim SC Semin Arthritis Rheum; 2021 Dec; 51(6):1242-1250. PubMed ID: 34757241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]